Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

963
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
963
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

3.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.0K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.9K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.8K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small airway dysfunction across alpha-1 antitrypsin deficiency genotypes with preserved spirometry.

European journal of applied physiology·2026
Same author

Alpha-1 Antitrypsin Replacement Improves Walking Capacity in Subjects With Severe Deficiency.

Respiratory care·2026
Same author

COVID-19 in people with Cystic Fibrosis beyond the pre-omicron era: a prospective study with a specific focus on long COVID.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025
Same author

A rare case of sudden blindness following mepolizumab withdrawal in EGPA.

Current medical research and opinion·2025
Same author

Post-COVID-19 exaggerated exertional tachycardia: Relationship with pulmonary and cardiac sequelae.

Heart & lung : the journal of critical care·2025
Same author

Breathing pattern and ventilatory response to exercise in patients with Chronic Obstructive Pulmonary Disease.

Respiratory physiology & neurobiology·2025

Related Experiment Video

Updated: Nov 17, 2025

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
12:08

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells

Published on: March 10, 2016

11.5K

Asthma phenotypes and endotypes in childhood.

Valentina Fainardi1, Susanna Esposito2, Alfredo Chetta3

  • 1Department of Medicine and Surgery, Clinic of Pediatrics, Pietro Barilla Children's Hospital, University of Parma, Parma, Italy - valentina.fainardi@unipr.it.

Minerva Medica
|February 12, 2021
PubMed
Summary

Asthma is a complex childhood disease with various phenotypes and endotypes. Understanding these classifications aids in developing personalized treatment strategies for better asthma management.

More Related Videos

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.8K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.2K

Related Experiment Videos

Last Updated: Nov 17, 2025

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
12:08

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells

Published on: March 10, 2016

11.5K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.8K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.2K

Area of Science:

  • Pediatric Pulmonology
  • Immunology
  • Clinical Medicine

Background:

  • Asthma is a heterogeneous respiratory condition with diverse clinical presentations.
  • Classifications based on phenotype (clinical features) and endotype (immunopathological mechanisms) are crucial for understanding asthma.
  • Identifying reliable biomarkers for endotypes remains a challenge.

Purpose of the Study:

  • To review and discuss the main phenotypes and endotypes of asthma recognized in children.
  • To highlight the importance of deep knowledge of patient phenotype and endotype.
  • To emphasize how this knowledge can guide tailored therapeutic approaches.

Main Methods:

  • Literature review of existing classifications and research on pediatric asthma phenotypes.
  • Analysis of immunopathological mechanisms and biomarker identification for asthma endotypes.
  • Synthesis of current understanding of asthma heterogeneity in children.

Main Results:

  • Detailed discussion of various pediatric asthma phenotypes, including age of onset, triggers, comorbidities, and treatment response.
  • Exploration of different asthma endotypes based on underlying immune pathways.
  • Emphasis on the clinical utility of distinguishing between phenotypes and endotypes.

Conclusions:

  • A thorough understanding of asthma phenotypes and endotypes is essential for personalized medicine in pediatric asthma.
  • Tailored therapeutic strategies informed by detailed patient classification can improve asthma outcomes.
  • Further research into reliable biomarkers for endotype identification is warranted.